市場調查報告書
商品編碼
1403396
手術敷料市場至2030年的預測:按產品、應用、最終用戶和地區分類的全球分析Surgical Dressing Market Forecasts to 2030 - Global Analysis By Product, By Application, End User and By Geography |
根據 Stratistics MRC 的資料,2023年全球手術敷料市場規模為 51 億美元,預計在預測期內將以 7.6%的年複合成長率成長,到2030年達到 86 億美元。
手術敷料是指應用於傷口或切口以促進癒合和預防感染的無菌材料。它們由紗布、繃帶和膠帶組成,用於吸收滲出液、保護傷口免受污染,並維持適當的復健環境。好處包括最大限度地降低感染風險、支持組織修復和提供舒適感。手術敷料對於術後護理、損傷治療和傷口處理非常重要。
根據美國整形外科醫師協會統計,2018年美國約有1,800萬人接受了微創整容手術。
慢性病增加
隨著糖尿病和心血管疾病等疾病的日益流行,對有效創傷護理和感染預防的需求日益增加。此外,由於人口老化,關節重建和心血管手術等手術數量不斷增加。手術敷料在術後護理中發揮著非常重要的作用,提供無菌屏障,最大限度地降低感染風險,並促進最佳創傷治療。隨著世界各地的醫療保健系統應對這些挑戰,對先進、高效的手術敷料的需求持續成長。
先進產品高成本
技術先進的手術敷料融合了智慧材料、抗菌劑和先進的創傷治療技術,通常價格較高。這對普及提出了挑戰,特別是在預算有限的醫療保健系統和注重成本的消費者中。患者和醫療保健提供者的經濟負擔限制了這些先進解決方案的使用,並阻礙了採用更具成本效益的選擇。
提高預防感染意識
醫療保健意識的提高強調了創傷護理中預防感染的重要性。這種認知的提高推動了對具有增強抗菌和預防感染特性的先進手術敷料的需求。消費者和醫療保健提供者積極尋找不僅能促進創傷治療還能最大限度地降低感染風險的產品。這一趨勢為市場相關人員引進和普及創新手術敷料打開了大門,創造了預防感染至上的市場環境。也開拓抗菌技術市場的發展,並透過有效且認可的產品來定位市場,以滿足不斷變化的醫療保健需求。
供應鏈中斷
地緣政治緊張局勢、自然災害和全球流行病等因素可能會擾亂供應鏈,導致手術敷料關鍵成分短缺。這些中斷不僅影響生產計劃,還會導致成本增加和物流挑戰。由於對全球供應鏈的依賴,市場很容易受到製造商無法控制的外部因素的影響。為了減輕這種威脅,產業公司必須投資於彈性供應鏈管理策略,以實現採購多元化,並制定緊急時應對計畫。積極採取措施對於確保材料的穩定供應、維持市場上手術敷料的不間斷供應以及防止對患者照護和醫療基礎設施的潛在負面影響非常重要。
COVID-19 的爆發對手術敷料市場產生了重大影響,導致世界各地醫療機構對創傷護理產品的需求增加。與病毒相關的住院和手術激增增加了對無菌敷料和先進創傷護理解決方案的需求。此外,大流行加速了遠端醫療的採用,並影響了適合遠距患者照護的手術敷料的開發。供應鏈中斷、醫療保健優先事項的轉變以及醫療保健系統的壓力進一步影響 COVID-19 期間和之後手術敷料市場的動態。
預計二次選礦產業在預測期間規模最大
二次選礦行業預計將出現良好的成長。二次敷料增加了對主要敷料的保護、滲出物吸收和支撐,以確保最佳的創傷治療條件。輔助敷料通常用於固定複雜傷口和主要敷料,有多種形式,包括紗布、薄膜、發泡體和親水膠體。有助於維持無菌環境、預防感染並提高病患舒適度。二次敷料用途廣泛且適應性強,使其成為全面傷口護理方案的重要組成部分,滿足不同患者的需求並有助於整體積極的結果。
預計醫院產業在預測期內年複合成長率最高。
預計醫院產業在預測期內將以最快的年複合成長率成長。手術敷料對於醫院的術後護理、傷口處理和感染預防非常重要。手術量的增加和對感染控制的重視推動對先進手術敷料解決方案的需求。醫院優先考慮使用無菌且有效的敷料,以最佳化患者的治療效果。此外,醫院和手術敷料製造商之間的持續合作有助於創新產品的開發,滿足醫療保健專業人員和患者在不同醫療保健情境中的特定需求。
在預測期內,在強大的醫療基礎設施、先進的醫療技術以及需要手術干預的慢性疾病患病率較高的推動下,北美手術敷料市場預計將繼續佔據大部分市場佔有率。該地區擁有完善的法律規範,可確保手術敷料的品質和安全並增強消費者信心。此外,人口老化也導致對術後護理產品的需求增加。持續的技術創新和感染預防意識的提高進一步推動了市場對醫療保健和支持市場生態系統的濃厚興趣。
預計亞太地區在預測期內年複合成長率最高。人口的成長、醫療保健支出的增加以及對先進創傷護理解決方案的認知不斷提高,都有助於市場的擴張。在中國和印度等國家,外科手術的迅速增加和慢性病盛行率的上升推動對外科敷料的需求。該地區也經歷創傷護理產品的創新。隨著醫療保健基礎設施的改善和對患者治療結果的重視,亞太地區成為手術敷料製造商的關鍵市場,為成長和市場滲透提供了機會。
According to Stratistics MRC, the Global Surgical Dressing Market is accounted for $5.1 billion in 2023 and is expected to reach $8.6 billion by 2030 growing at a CAGR of 7.6% during the forecast period. Surgical dressing refers to sterile materials applied to wounds or incisions to promote healing and prevent infection. Comprising gauze, bandages, and adhesive strips, it serves to absorb exudates, protect the wound from contaminants, and maintain a conducive environment for recovery. Advantages include minimizing infection risks, supporting tissue repair, and providing comfort. Surgical dressings are crucial in postoperative care, injury treatment, and wound management.
According to the American Society of Plastic Surgeons, approximately 18 million people in the U.S. underwent minimally invasive cosmetic surgical procedures in 2018.
With an increasing incidence of conditions like diabetes and cardiovascular diseases, there's a heightened need for effective wound care and infection prevention. Additionally, the growing aging population contributes to a higher number of surgeries, such as joint replacements and cardiac procedures. Surgical dressings play a pivotal role in postoperative care by providing a sterile barrier, minimizing infection risks, and promoting optimal wound healing. As healthcare systems globally address these challenges, the demand for advanced and efficient surgical dressing solutions continues to rise.
Technologically advanced surgical dressings incorporating smart materials, antimicrobial agents, and sophisticated wound-healing technologies often come with a higher price tag. This poses a challenge to widespread adoption, particularly in healthcare systems with budget constraints and cost-conscious consumers. The economic burden on patients and healthcare providers limits the accessibility of these advanced solutions, hindering their adoption in favor of more cost-effective alternatives.
As healthcare awareness grows, there is a heightened emphasis on the importance of infection control in wound care. This awareness is driving demand for advanced surgical dressings with enhanced antimicrobial properties and infection-resistant features. Consumers and healthcare providers are actively seeking products that not only facilitate wound healing but also minimize the risk of infections. This trend opens doors for market players to introduce and promote innovative surgical dressing solutions, fostering a market environment where infection prevention is a key consideration. It also encourages the development of antimicrobial technologies, positioning the market to address evolving healthcare needs with effective and awareness-driven products.
Factors such as geopolitical tensions, natural disasters, or global pandemics can disrupt the supply chain, leading to shortages of critical components for surgical dressings. These disruptions not only affect production timelines but also contribute to increased costs and logistical challenges. The dependence on a global supply chain makes the market vulnerable to external factors beyond the control of manufacturers. To mitigate this threat, industry players must invest in resilient supply chain management strategies, diversify sourcing options, and establish contingency plans. Proactive measures are essential to ensure a stable supply of materials and maintain the uninterrupted availability of surgical dressings in the market, safeguarding against potential adverse impacts on patient care and healthcare infrastructure.
The COVID-19 pandemic has significantly impacted the Surgical Dressing Market, leading to increased demand for wound care products in healthcare facilities globally. With a surge in hospitalizations and surgeries related to the virus, there has been a heightened need for sterile dressings and advanced wound care solutions. Additionally, the pandemic has accelerated the adoption of telemedicine, influencing the development of surgical dressings suitable for remote patient care. Supply chain disruptions, fluctuating healthcare priorities, and the strain on healthcare systems have further shaped the dynamics of the surgical dressing market during and post-COVID-19.
The secondary dressing segment is expected to have a lucrative growth. These dressings provide added protection, absorption of exudate, and support to the primary dressing, ensuring optimal wound healing conditions. Commonly used in complex wounds or to secure primary dressings, secondary dressings come in various forms, such as gauze, films, foams, or hydrocolloids. They contribute to maintaining a sterile environment, preventing infections, and promoting patient comfort. The versatility and adaptability of secondary dressings make them integral in comprehensive wound care protocols, catering to diverse patient needs and contributing to overall positive treatment outcomes.
The hospitals segment is anticipated to witness the fastest CAGR growth during the forecast period. Surgical dressings are integral in postoperative care, wound management, and infection prevention within hospital settings. The rising number of surgeries, coupled with a growing emphasis on infection control, propels the demand for advanced surgical dressing solutions. Hospitals prioritize the use of sterile and effective dressings to ensure optimal patient outcomes. Moreover, ongoing collaborations between hospitals and surgical dressing manufacturers contribute to the development of innovative products, addressing the specific needs of healthcare professionals and patients in diverse medical scenarios.
During the forecast period, it is expected that the North American Surgical Dressing market will continue to hold a majority of the market share driven by a robust healthcare infrastructure, advanced medical technologies, and a high prevalence of chronic diseases requiring surgical interventions. The region's well-established regulatory framework ensures the quality and safety of surgical dressings, fostering trust among consumers. Additionally, a growing aging population contributes to an increased demand for postoperative care products. Ongoing technological innovations and the rising awareness of infection prevention further propel the market with a strong focus on healthcare and a supportive market ecosystem.
Asia Pacific is projected to have the highest CAGR over the forecast period. The growing population, increasing healthcare expenditures, and rising awareness about advanced wound care solutions contribute to the market's expansion. In countries like China and India, a surge in surgical procedures, coupled with a higher prevalence of chronic diseases, fuels the demand for surgical dressings. The region also witnesses ongoing technological innovations in wound care products. With improving healthcare infrastructure and a focus on patient outcomes, Asia Pacific represents a key market for surgical dressing manufacturers, presenting opportunities for growth and market penetration.
Some of the key players in Surgical Dressing market include 3M Company, B. Braun SE, Baxter, Smith and Nephew plc., Cardinal Health Inc., Organogenesis Holdings Inc., Coloplast Corp, Molnlycke Health Care AB, Convatec Group PLC, Derma Sciences Inc. (Integra LifeSciences), Essity Aktiebolag AB, Johnson & Johnson Private Limited and Medtronic.
In August 2023, TE Connectivity announced the launch of its new line of hybrid fiber optic connectors.
In April 2023, the FDA clearance for 3M Health Care's 3M Veraflo Therapy, including 3M V.A.C. Veraflo Cleanse Choice Dressing, and 3M Veraflo Cleanse Choice Complete Dressing expanded the company's customer base and increased its revenue. This innovative approach for wound care offered improved treatment options, making it more attractive to healthcare providers and potentially boosting the company's financial performance.
In January 2023, Convatec announced the U.S. launch of ConvaFoam, a family of advanced foam dressings that can be used on a spectrum of wound types at any stage for wound management and skin protection.
In June 2022, Collagen Matrix received 510(k) clearance for a new fibrillar collagen wound dressing. The collagen matrix fibrillar collagen wound dressing is an absorbent microfibrillar matrix used to treat wounds that moderately to extensively exude fluid as well as control mild bleeding.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.